In the current study, a combination of QUE and SFN was found to inhibit HCT116 xenograft tumor growth in synergy with OXP by inhibiting GR activity, lowering GSH level, increasing cellular oxidative stress, and thereby inducing apoptotic cell death. The gene discussed is GSR; the disease is neoplasm.